1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Topic was temporarily posted March 2, 2026 and removed the following day. Estimated deadline was April 29, 2026, but the solicitation is no longer active — it was removed pending reauthorization.
"Development of Wearable Device for Detecting Biomarkers and Treating Viral..." is currently closed and not accepting applications.
Development of Wearable Device for Detecting Biomarkers and Treating Viral... is sponsored by Defense Health Agency (DHA). This grant focuses on the development of wearable devices for detecting biomarkers and treating viral infections, with implications for military personnel.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Development of Wearable Device for Detecting Biomarkers and Treating Viral and Bacterial Infections - SBIR DHA26BZ01-NV004 — BW&CO Development of Wearable Device for Detecting Biomarkers and Treating Viral and Bacterial Infections - SBIR DHA26BZ01-NV004 Active specific topic DSIP This topic was temporarily posted by the Department of War SBIR Program on March 2nd 2026 and removed the following day.
We believe this topic is planned to be released once the SBIR program is reauthorized; however, this topic may ultimately be modified or withdrawn. Notify Me When This is Released Develop a non-invasive wearable device that can discretely detect biomarkers for and provide initial broad-spectrum treatment for pan-viral and pan-bacterial infections. If fielded for military use, it may require additional security measures.
The DHA Strategic Research Plan (SRP): Environmental Exposures (June 2024) lists two capability requirements under the “Assess” and “Treat” capability areas that align with this proposal: Environmental Detection and Health Risk Assessments under Assess and Environmental Exposures Treatment under Treat.
In addition, the DHA SRP: Military Infectious Diseases (May 2024) lists three capability requirements under the “Prevent”, “Treat”, and “Enable” capability areas that align with this proposal: Prevention of Military Relevant Endemic and Emerging Infectious Diseases under Prevent, Treatment of Military Relevant Endemic and Emerging Infectious Diseases under Treat, and Core Competencies under Enable.
The Department of the Air Force (DAF) is looking for an advanced, non-invasive (does not break the skin or physically enter the body) wearable device (i.e., flash/continuous glucose style monitoring) capable of qualitatively detecting all-viral and all-bacterial infections using discrete biomarkers for such infections: TRAIL, MxA, CD46, IP-10, PTX3, or other non-blood based biomarkers (saliva, sweat, etc.) for viral infections and CRP, PCT, IL-6, IL-8, CD35, CD55, CD64, pro-ADM, or other non-blood based biomarkers (saliva, sweat, etc.) for bacterial infections.
The end goal is a wearable device that discretely detects viral and bacterial infections and renders initial, broad-spectrum anti-viral or anti-bacterial treatment(s) at austere operational environments where no immediate medical countermeasures and no other detection capabilities are available until casualties are evacuated to locations with more robust medical resources for additional and specific differentiation and treatment.
At a higher echelon of care, medical personnel must be able to receive data from the device to find out what category of threats (viral or bacterial) has triggered a biomarker detection and what corresponding treatments have been rendered to the affected force before providing more advanced care.
By continuously monitoring validated biomarkers, this device will empower warfighters to detect and respond to biological threats early, enhancing their survivability and operational effectiveness in high-threat theaters and mitigating risks to mission and force. This Air Force Medical Command initiative improves force health protection and ensures mission success.
Dual-use functionality of this technology will focus on civilian healthcare systems. If you can achieve the objective above better than any other company on the market, you have a very high-likelihood of success and should apply. Who is eligible to apply?
Any company that meets the following criteria: U.S.-owned and controlled. 500 or fewer employees (including affiliates) 1) End-to-end support including, strategy, writing of the full proposal, and administrative & compliance support. 2) Proposal strategy and review.
3) Administrative & compliance support. Request to talk with a member of our team by completing the form below: Biotech healthtech Medtech Defense & Dual Use Technology DHA Artificial Intelligence & Machine Learning https://www. bwcoconsulting.
com Environmental Exposure Detection Technologies and/or Decontamination Treatments for Military Working Dogs - SBIR DHA26BZ01-NV003 Detection and Treatment of Traumatic Brain Injury in Military Working Dogs - SBIR DHA26BZ01-NV002
According to the current listing, eligibility includes: Not explicitly detailed, but likely targets organizations with expertise in medical device development, biosensors, and infectious disease research. Confirm the full requirements in the official notice before applying.
The published deadline was June 3, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Development of Wearable Device for Detecting Biomarkers and Treating Viral... is funded by Defense Health Agency (DHA). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
BAA for Extra Mural Medical Research - HT942523SBAA1 is sponsored by Defense Health Agency (DHA). The Defense Health Agency is seeking proposals for funding in support of research areas including Military Infectious Diseases (R&D of solutions for prevention, treatment, and diagnosis), Combat Casualty Care (R&D of products to stop blood loss, resuscitate, and limit consequenc…
DHA Small Business Innovation Research (SBIR) Program is sponsored by Defense Health Agency (DHA). The DHA SBIR program funds biomedical and health-focused technologies that enhance medical readiness, clinical care delivery, force health protection, operational medicine, and military healthcare modernization. This includes digital health systems, AI-enabled triage, portable medical devices, and physiological monitoring tools for austere environments.
HRSA-27-006 and HRSA-27-007 post September 18, 2026 and both close October 19 — $711.4 million across 189 awards for service areas that already have a health center in them. The incumbent is defending. Everyone else is holding a free option.
Read articleCDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleUSDA has obligated roughly $1 billion in emergency funds against New World screwworm and awarded $105 million to 40 Grand Challenge projects from 226 proposals. On September 2, 2026, DARPA pre-released a $2.1 million SBIR topic for networked screwworm detection. Four funding streams, four eligibility regimes, four clockspeeds — and most applicants only know about one.
Read article